FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067884089> ?p ?o ?g. }

• W2067884089 endingPage "628" @default.
• W2067884089 startingPage "619" @default.
• W2067884089 abstract "Androgen withdrawal is the only effective therapy for patients with advanced prostate cancer, but progression to androgen independence ultimately occurs in almost all patients. Novel therapeutic strategies targeting molecular mechanisms that mediate resistance to hormonal and chemotherapeutic treatment are highly warranted. Here, we aimed to evaluate the expression of potential therapeutic targets in advanced prostate cancer. A tissue microarray (TMA) containing samples from 535 tissue blocks was constructed, including benign prostatic hyperplasia as controls (n = 65), prostatic intraepithelial neoplasia (PIN; n = 78), clinically localized prostate cancers (n = 181), as well as hormone-refractory local recurrences (n = 120) and distant metastases (n = 91). The expression of 13 different proteins was analyzed using immunohistochemistry (Bcl-2, p53, ILK, Syndecan-1, MUC-1, EGFR, HER2/neu, HSP-90, Ep-CAM, MMP-2, CD-10, CD-117 and Ki67). Significant overexpression in hormone-refractory prostate cancer and metastatic tissue compared to localized prostate cancer was found for Ki67 (64% vs. 9%), Bcl-2 (11% vs. 1%), p53 (35% vs. 4%), Syndecan-1 (38% vs. 3%), EGFR (16% vs. 1%) and HER2/neu (16% vs. 0%). Overexpression of CD-117 was restricted to 1 single metastasis. All other markers did not show relevant differences in expression between subgroups. Taken together, p53, Bcl-2, Syndecan-1, EGFR and HER2/neu are preferentially expressed in hormone-refractory and metastatic prostate cancer. Selected inhibition of these targets might offer a strategy to treat advanced tumors and prevent further progression. Treatment decisions should not be based on findings in primary tumors but rather on tissues from recurrent or metastatic lesions." @default.
• W2067884089 created "2016-06-24" @default.
• W2067884089 creator A5000570624 @default.
• W2067884089 creator A5024459881 @default.
• W2067884089 creator A5026023265 @default.
• W2067884089 creator A5051573913 @default.
• W2067884089 creator A5062696264 @default.
• W2067884089 creator A5064829089 @default.
• W2067884089 creator A5067223235 @default.
• W2067884089 creator A5085335231 @default.
• W2067884089 creator A5086949891 @default.
• W2067884089 date "2004-01-01" @default.
• W2067884089 modified "2023-10-18" @default.
• W2067884089 title "Expression patterns of potential therapeutic targets in prostate cancer" @default.
• W2067884089 cites W150141157 @default.
• W2067884089 cites W1580523172 @default.
• W2067884089 cites W1967252809 @default.
• W2067884089 cites W1967421034 @default.
• W2067884089 cites W1970565451 @default.
• W2067884089 cites W1975483746 @default.
• W2067884089 cites W1977278230 @default.
• W2067884089 cites W1979345358 @default.
• W2067884089 cites W1980480809 @default.
• W2067884089 cites W1983704893 @default.
• W2067884089 cites W1985211662 @default.
• W2067884089 cites W1987483436 @default.
• W2067884089 cites W1988698591 @default.
• W2067884089 cites W1989856647 @default.
• W2067884089 cites W1991074325 @default.
• W2067884089 cites W1992893580 @default.
• W2067884089 cites W1999520767 @default.
• W2067884089 cites W2006115709 @default.
• W2067884089 cites W2013669069 @default.
• W2067884089 cites W2013707964 @default.
• W2067884089 cites W2020283231 @default.
• W2067884089 cites W2021861003 @default.
• W2067884089 cites W2024662272 @default.
• W2067884089 cites W2025765277 @default.
• W2067884089 cites W2026162932 @default.
• W2067884089 cites W2037472196 @default.
• W2067884089 cites W2038762634 @default.
• W2067884089 cites W2043696829 @default.
• W2067884089 cites W2046343296 @default.
• W2067884089 cites W2049299149 @default.
• W2067884089 cites W2054792292 @default.
• W2067884089 cites W2057021679 @default.
• W2067884089 cites W2059065591 @default.
• W2067884089 cites W2063999966 @default.
• W2067884089 cites W2070393254 @default.
• W2067884089 cites W2071416007 @default.
• W2067884089 cites W2077628380 @default.
• W2067884089 cites W2081991489 @default.
• W2067884089 cites W2087810003 @default.
• W2067884089 cites W2088879795 @default.
• W2067884089 cites W2089426804 @default.
• W2067884089 cites W2095734305 @default.
• W2067884089 cites W2105829250 @default.
• W2067884089 cites W2114248978 @default.
• W2067884089 cites W2120435603 @default.
• W2067884089 cites W2124749346 @default.
• W2067884089 cites W2126314379 @default.
• W2067884089 cites W2129040492 @default.
• W2067884089 cites W2131833467 @default.
• W2067884089 cites W2154304757 @default.
• W2067884089 cites W2158691858 @default.
• W2067884089 cites W2161821474 @default.
• W2067884089 cites W2167368130 @default.
• W2067884089 cites W2312340796 @default.
• W2067884089 cites W2317651908 @default.
• W2067884089 cites W2318605753 @default.
• W2067884089 cites W2320975508 @default.
• W2067884089 cites W2326916312 @default.
• W2067884089 cites W2329648702 @default.
• W2067884089 cites W2395122332 @default.
• W2067884089 cites W2395864799 @default.
• W2067884089 cites W41590078 @default.
• W2067884089 cites W4239989216 @default.
• W2067884089 doi "https://doi.org/10.1002/ijc.20615" @default.
• W2067884089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15472903" @default.
• W2067884089 hasPublicationYear "2004" @default.
• W2067884089 type Work @default.
• W2067884089 sameAs 2067884089 @default.
• W2067884089 citedByCount "153" @default.
• W2067884089 countsByYear W20678840892012 @default.
• W2067884089 countsByYear W20678840892013 @default.
• W2067884089 countsByYear W20678840892014 @default.
• W2067884089 countsByYear W20678840892015 @default.
• W2067884089 countsByYear W20678840892016 @default.
• W2067884089 countsByYear W20678840892018 @default.
• W2067884089 countsByYear W20678840892019 @default.
• W2067884089 countsByYear W20678840892020 @default.
• W2067884089 countsByYear W20678840892021 @default.
• W2067884089 countsByYear W20678840892022 @default.
• W2067884089 countsByYear W20678840892023 @default.
• W2067884089 crossrefType "journal-article" @default.
• W2067884089 hasAuthorship W2067884089A5000570624 @default.
• W2067884089 hasAuthorship W2067884089A5024459881 @default.
• W2067884089 hasAuthorship W2067884089A5026023265 @default.

• next